Zacks Investment Research lowered shares of Genpact Limited (NYSE:G) from a hold rating to a sell rating in a report published on Friday.

According to Zacks, “Genpact is a dominant name in the Business process outsourcing (BPO) market based on its domain expertise in business analytics, digital and consulting.  We also note that it is gaining popularity among customers in providing emerging technologies like Blockchain and Industrial Internet of Things (IoT). Moreover, accretive acquisitions over the years have aided the company penetrate new domains like mobile technology, dynamic workflow solution and artificial intelligence (AI). Additionally, effective cost management is driving operating margin expansion. Estimates have been stable ahead of the company's Q2 earnings release. The company has mixed record of earnings surprises in the recent quarters. However, anticipated government regulation in the U.S. over outsourcing (H1B Visa, Cross-border tax), dependency on GE for top-line growth, high-debt levels and stretched valuation are headwinds.”

Separately, BidaskClub raised shares of Genpact Limited from a buy rating to a strong-buy rating in a report on Wednesday, June 28th. Two research analysts have rated the stock with a sell rating, one has given a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of $26.50.

Genpact Limited (NYSE:G) traded down 0.07% during trading on Friday, hitting $28.98. 68,870 shares of the company were exchanged. The company has a market capitalization of $5.59 billion, a price-to-earnings ratio of 22.77 and a beta of 0.50. The stock’s 50-day moving average is $27.91 and its 200-day moving average is $25.64. Genpact Limited has a 12 month low of $22.58 and a 12 month high of $29.19.

Genpact Limited (NYSE:G) last announced its quarterly earnings data on Thursday, May 4th. The business services provider reported $0.29 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.29. Genpact Limited had a net margin of 10.23% and a return on equity of 22.24%. The firm had revenue of $623 million during the quarter, compared to analyst estimates of $614.84 million. During the same quarter in the prior year, the firm posted $0.31 earnings per share. Genpact Limited’s quarterly revenue was up 2.2% on a year-over-year basis. Equities research analysts anticipate that Genpact Limited will post $1.55 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This report was originally reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another publication, it was illegally copied and republished in violation of U.S. & international copyright law. The original version of this report can be read at https://www.watchlistnews.com/zacks-investment-research-lowers-genpact-limited-g-to-sell/1465840.html.

In other Genpact Limited news, insider Mohit Thukral sold 27,228 shares of the stock in a transaction dated Tuesday, May 30th. The shares were sold at an average price of $27.21, for a total transaction of $740,873.88. Following the completion of the transaction, the insider now owns 68,845 shares of the company’s stock, valued at $1,873,272.45. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director James C. Madden sold 5,224 shares of the stock in a transaction dated Friday, May 12th. The stock was sold at an average price of $25.51, for a total transaction of $133,264.24. Following the transaction, the director now directly owns 8,970 shares of the company’s stock, valued at approximately $228,824.70. The disclosure for this sale can be found here. Corporate insiders own 1.55% of the company’s stock.

Hedge funds and other institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC bought a new position in shares of Genpact Limited during the first quarter valued at $110,000. Bronfman E.L. Rothschild L.P. raised its position in shares of Genpact Limited by 42.5% in the first quarter. Bronfman E.L. Rothschild L.P. now owns 4,959 shares of the business services provider’s stock valued at $123,000 after buying an additional 1,480 shares during the period. BNP Paribas Arbitrage SA raised its position in shares of Genpact Limited by 85.3% in the first quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock valued at $129,000 after buying an additional 2,403 shares during the period. OLD Mutual Customised Solutions Proprietary Ltd. acquired a new stake in shares of Genpact Limited during the first quarter valued at about $168,000. Finally, Quantitative Systematic Strategies LLC acquired a new stake in shares of Genpact Limited during the second quarter valued at about $211,000. 94.01% of the stock is owned by institutional investors.

Genpact Limited Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Get a free copy of the Zacks research report on Genpact Limited (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Genpact Limited (NYSE:G)

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.